A 64-year-old man with a 45-pack-year smoking history undergoes lung cancer screening with a low-dose computed tomography (CT) scan of the chest. The scan reveals a new, incidental 25-mm, noncalcified, solid lung mass with spiculated margins in the apical segment of the right upper lobe. No prior imaging is available for comparison. He is currently asymptomatic, and his physical examination is unremarkable. His estimated pretest probability for primary lung malignancy is considered very high. Arrange the following diagnostic modalities in the most appropriate chronological sequence for the stepwise clinical evaluation and initial staging of this patient's pulmonary mass.
- 1Fluorodeoxyglucose positron emission tomography-computed tomography (FDG PET-CT) scan
- 2Image-guided percutaneous core needle biopsy
- 3Magnetic resonance imaging (MRI) of the brain with intravenous contrast
Answer
The correct chronological sequence is to first perform an FDG PET-CT scan for metabolic staging, followed by an image-guided core needle biopsy for definitive tissue diagnosis, and finally a contrast-enhanced MRI of the brain to complete clinical staging.
The evaluation of a highly suspicious pulmonary mass involves a stepwise approach to confirm the diagnosis and establish the clinical stage while minimizing patient risk. The first step is to obtain an FDG PET-CT scan. This whole-body imaging modality assesses the metabolic activity of the primary tumor, evaluates for regional lymph node involvement, and screens for distant metastases. Crucially, the PET-CT scan guides the next step—tissue diagnosis—by identifying the most accessible and informative site for an image-guided core needle biopsy. If a distant metastasis is identified on PET-CT, biopsying that site confirms both the histologic diagnosis and Stage IV disease in a single procedure. Finally, after lung cancer is histologically confirmed, a contrast-enhanced MRI of the brain is required to rule out occult central nervous system metastases, as PET-CT is poorly sensitive for brain lesions due to high physiological cortical glucose uptake.
Step-by-Step Solution
Key Concept
The diagnostic sequence for a highly suspicious pulmonary mass involves initial noninvasive metabolic staging (PET-CT) to map disease extent and guide tissue acquisition (biopsy), followed by targeted neuroimaging (Brain MRI) to rule out occult metastases once a cancer diagnosis is histologically confirmed.
Estimated Time:1m 30s